RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)
Price and Volume
Detailed Quote| Volume | 356,616 |
| Open | 28.07 |
| Bid (Size) | 11.31 (200) |
| Ask (Size) | 29.76 (100) |
| Prev. Close | 28.65 |
| Today's Range | 27.95 - 28.86 |
| 52wk Range | 5.666 - 42.39 |
| Shares Outstanding | 34,358,152 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
October 21, 2025
12 Health Care Stocks Moving In Monday's Intraday Session ↗
October 20, 2025
These stocks are moving in today's pre-market session ↗
October 20, 2025
RAPT Therapeutics Reports Second Quarter 2025 Financial Results
August 07, 2025
Frequently Asked Questions
Is RAPT Therapeutics, Inc. - Common Stock publicly traded?
Yes, RAPT Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does RAPT Therapeutics, Inc. - Common Stock trade on?
RAPT Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RAPT Therapeutics, Inc. - Common Stock?
The ticker symbol for RAPT Therapeutics, Inc. - Common Stock is RAPT on the Nasdaq Stock Market
What is the current price of RAPT Therapeutics, Inc. - Common Stock?
The current price of RAPT Therapeutics, Inc. - Common Stock is 28.28
When was RAPT Therapeutics, Inc. - Common Stock last traded?
The last trade of RAPT Therapeutics, Inc. - Common Stock was at 11/18/25 04:00 PM ET
What is the market capitalization of RAPT Therapeutics, Inc. - Common Stock?
The market capitalization of RAPT Therapeutics, Inc. - Common Stock is 971.65M
How many shares of RAPT Therapeutics, Inc. - Common Stock are outstanding?
RAPT Therapeutics, Inc. - Common Stock has 972M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube